Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wai-Kay Seto

Showing results (311-320 of 326) with videos related to

Pageof 33
Sort By:
Gastroenterology|September 28, 2023
HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral TherapyMilan J Sonneveld, Shao-Ming Chiu, Jun Yong Park, et al.
Journal of Hepatology|January 8, 2025
Predictors of hepatic flares after nucleos(t)ide analogue cessation - Results of a global cohort study (RETRACT-B study)Edo J Dongelmans, Grishma Hirode, Bettina E Hansen, et al.
Journal of Hepatology|May 15, 2018
96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infectionKosh Agarwal, Maurizia Brunetto, Wai Kay Seto, et al.
JHEP Reports : Innovation in Hepatology|December 17, 2024
Application of a deep learning algorithm for the diagnosis of HCCPhilip Leung Ho Yu, Keith Wan-Hang Chiu, Jianliang Lu, et al.
Journal of Hepatology|April 1, 2026
Long-term outcomes after nucleos(t)ide analogue cessation in chronic hepatitis B - follow-up from the RETRACT-B cohortEdo Dongelmans, Grishma Hirode, Florian van Bӧmmel, et al.
Scientific Reports|May 23, 2018
Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinomaHiromi Sawai, Nao Nishida, Seik-Soon Khor, et al.
Plos One|February 13, 2014
New susceptibility and resistance HLA-DP alleles to HBV-related diseases identified by a trans-ethnic association study in AsiaNao Nishida, Hiromi Sawai, Koichi Kashiwase, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 10, 2025
Global Burden of Major Chronic Liver Diseases in 2021Gong Feng, Yusuf Yilmaz, Luca Valenti, et al.
The American Journal of Gastroenterology|January 3, 2025
Global, Regional, and National Burden of Primary Liver Cancer Attributable to Metabolic Risks: An Analysis of the Global Burden of Disease Study 1990-2021Chutian Wu, Giovanni Targher, Christopher D Byrne, et al.
Gastroenterology|July 25, 2025
Enhancement of Inpatient Mortality Prognostication With Machine Learning in a Prospective Global Cohort of Patients With Cirrhosis With External ValidationScott Silvey, Patrick S Kamath, Jacob George, et al.
Pageof 33

Showing results (311-320 of 326) with videos related to

Sort By:
Pageof 33
Gastroenterology|September 28, 2023
HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral TherapyMilan J Sonneveld, Shao-Ming Chiu, Jun Yong Park, et al.
Journal of Hepatology|January 8, 2025
Predictors of hepatic flares after nucleos(t)ide analogue cessation - Results of a global cohort study (RETRACT-B study)Edo J Dongelmans, Grishma Hirode, Bettina E Hansen, et al.
Journal of Hepatology|May 15, 2018
96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infectionKosh Agarwal, Maurizia Brunetto, Wai Kay Seto, et al.
JHEP Reports : Innovation in Hepatology|December 17, 2024
Application of a deep learning algorithm for the diagnosis of HCCPhilip Leung Ho Yu, Keith Wan-Hang Chiu, Jianliang Lu, et al.
Journal of Hepatology|April 1, 2026
Long-term outcomes after nucleos(t)ide analogue cessation in chronic hepatitis B - follow-up from the RETRACT-B cohortEdo Dongelmans, Grishma Hirode, Florian van Bӧmmel, et al.
Scientific Reports|May 23, 2018
Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinomaHiromi Sawai, Nao Nishida, Seik-Soon Khor, et al.
Plos One|February 13, 2014
New susceptibility and resistance HLA-DP alleles to HBV-related diseases identified by a trans-ethnic association study in AsiaNao Nishida, Hiromi Sawai, Koichi Kashiwase, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 10, 2025
Global Burden of Major Chronic Liver Diseases in 2021Gong Feng, Yusuf Yilmaz, Luca Valenti, et al.
The American Journal of Gastroenterology|January 3, 2025
Global, Regional, and National Burden of Primary Liver Cancer Attributable to Metabolic Risks: An Analysis of the Global Burden of Disease Study 1990-2021Chutian Wu, Giovanni Targher, Christopher D Byrne, et al.
Gastroenterology|July 25, 2025
Enhancement of Inpatient Mortality Prognostication With Machine Learning in a Prospective Global Cohort of Patients With Cirrhosis With External ValidationScott Silvey, Patrick S Kamath, Jacob George, et al.
Pageof 33